Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

mdm2 mRNA level is a prognostic factor in soft tissue sarcoma.

H Taubert1, T Koehler, A Meye

  • 1Institute of Pathology, Martin-Luther-University of Halle-Wittenberg, Halle/Saale, Germany. helge.taubert@medizin.uni-halle.de

Molecular Medicine (Cambridge, Mass.)
|May 10, 2000
PubMed
Summary

Murine double minute-2 (mdm2) mRNA expression is a significant prognostic indicator in soft tissue sarcoma (STS). Lower mdm2 mRNA levels (<50 zmol/amol) are linked to reduced survival, highlighting its clinical relevance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia.

NeuroImage. Clinical·2019
Same author

Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2018
Same author

Etiology and clinical relevance of elevated platelet count in ICU patients : A retrospective analysis.

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2017
Same author

[Prognostic value of lacrimal duct diagnostics after tube removal : Retrospective analysis of risk of relapse during the first postoperative year after transcanalicular lacrimal duct surgery with silicone tubing].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2017
Same author

Serum IgG levels and mortality in patients with severe sepsis and septic shock : The SBITS data.

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2016
Same author

[Erratum to: Balloon dilatation of the Eustachian tube during middle ear surgery : Study planning and first experiences during recruitment].

HNO·2016

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Overexpression of murine double minute-2 (mdm2) protein, often interacting with tumor suppressor p53, has known oncogenic properties.
  • The clinical significance of mdm2 mRNA expression, however, remains under-investigated in cancer prognosis.

Purpose of the Study:

  • To investigate the clinical relevance of mdm2 mRNA expression as a prognostic factor in soft tissue sarcoma (STS).

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to analyze mdm2 mRNA expression in 65 STS samples.
  • Mdm2 mRNA levels were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression.

Main Results:

  • Patients with an mdm2/GAPDH mRNA ratio below 50 zmol/amol exhibited significantly reduced survival compared to those with a ratio of >=50 (p=0.0241).

Related Experiment Videos

  • Multivariate analysis confirmed mdm2 mRNA expression as an independent prognostic factor, with ratios <50 associated with a 5.6-fold increased risk in stages 2 and 3 (p=0.0041).
  • Specific mdm2 mRNA expression levels (100 to <500 zmol/amol) correlated with the best prognosis, while levels of 50 to <100 showed the worst prognosis within the higher expression group.

    • Conclusions:

    • Mdm2 mRNA expression levels serve as an independent prognostic biomarker for soft tissue sarcoma (STS) patients.
    • The findings suggest mdm2's role in STS development and its potential as a target for gene therapy.